HLA-C and hepatocellular carcinoma: This mechanism of aa changes within epitopes (escape mutations) interferes with both peptide processing reducing the intracellular antigen load and downregulation of MHC expression hence increased risk of developing liver malignancies (HCC, LC) among CHB patients [4,5,94,95,96,97,98].